Study in Advanced Solid Tumors

NCT01099358 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: Cetuximab
DRUG: Cisplatin
DRUG: 5 - Fluorouracil

Sponsor

Eli Lilly and Company